• 首页期刊简介编委会刊物订阅专栏专刊电子刊学术动态联系我们English
引用本文:刘勇锋,林玮玮,郭仙忠.基于群体药动学模型的奥卡西平个体化给药软件研制[J].中国现代应用药学,2020,37(20):2537-2542.
LIU Yongfeng,LIN Weiwei,GUO Xianzhong.Development of Software for Individualizing Dosage Regimens of Oxcarbazepine Based on Population Pharmacokinetics Models[J].Chin J Mod Appl Pharm(中国现代应用药学),2020,37(20):2537-2542.
【打印本页】   【HTML】   【下载PDF全文】   查看/发表评论  【EndNote】   【RefMan】   【BibTex】
←前一篇|后一篇→ 过刊浏览    高级检索
本文已被:浏览 1634次   下载 808 本文二维码信息
码上扫一扫!
分享到: 微信 更多
基于群体药动学模型的奥卡西平个体化给药软件研制
刘勇锋, 林玮玮, 郭仙忠
福建医科大学附属第一医院药学部, 福州 350005
摘要:
目的 研制基于群体药动学(population pharmacokinetics,PPK)模型的奥卡西平(oxcarbazepine,OXC)个体化给药软件。方法 根据已建立的成人和儿童OXC活性代谢物10,11-二氢-10-羟基卡马西平(monohydroxycarbazepine,MHD)的PPK模型信息,运用MyEclipse、SQL Server、JRE等工具研制OXC给药软件。软件开发方案包括软件需求分析、软件概要设计、软件详细设计、软件编码、软件测试以及软件维护和二次开发。结果 研制的OXC给药软件可实现患者信息输入和管理,能自动调用NONMEM软件,能预测多种具体给药方案下的MHD血药浓度,供临床制定初始给药方案参考,而且能结合已有的血药浓度监测信息和Bayesian反馈法更精准地预测血药浓度,辅助临床进一步优化给药方案。结论 基于MHD的PPK模型研制的给药软件能快捷方便地辅助成人和儿童癫痫患者OXC的个体化给药。
关键词:  奥卡西平  10,11-二氢-10-羟基卡马西平  群体药动学  个体化给药  给药软件
DOI:10.13748/j.cnki.issn1007-7693.2020.20.019
分类号:R969.1
基金项目:福建省科技厅引导性项目(2017Y0033);福建医科大学启航基金项目(2017XQ1068)
Development of Software for Individualizing Dosage Regimens of Oxcarbazepine Based on Population Pharmacokinetics Models
LIU Yongfeng, LIN Weiwei, GUO Xianzhong
Department of Pharmacy, The First Affiliated Hospital of Fujian Medical University, Fuzhou 350005, China
Abstract:
OBJECTIVE To develop a software for individualizing dosage regimens of oxcarbazepine(OXC) based on the population pharmacokinetics(PPK) models. METHODS OXC dosing software was developed by MyEclipse, SQL Server, JRE and so on, according to the monohydroxycarbazepine(MHD)'s PPK model of adults and children. The software developing schemes included requirement analysis, general design, detailed design, software coding, software test, software maintenance and software redevelopment. RESULTS The software was able to input and manage patient information, run NONMEM automatically, predict blood concentrations under various dosing regimens which could help initial dosage design, and predict blood concentrations more accurately based on therapeutic drug monitoring results and Bayesian method in dosage adjustment. CONCLUSION This new developed software based on MHD's PPK models can give assistance to facilitate the individualized therapy for epilepsy patients expediently.
Key words:  oxcarbazepine  monohydroxycarbazepine  population pharmacokinetics  dose individualization  dosing software
扫一扫关注本刊微信